• PAD Device Controversy Continues; TAVR Leaflet Laceration; Coronary Flow Reproducibility

    Interventional cardiology news to note

    The Early Bird Bleed Monitoring System got FDA approval for the detection and monitoring of vessel injury-related bleeding during endovascular procedures, manufacturer Saranas announced. Clearance for its de novo designation was based on an animal study.

    Among Medicare and Medicaid beneficiaries, drug-eluting stents were not associated with mortality when placed for peripheral artery revascularization, a report showed in the Journal of the American College of CardiologyMedpage Today has full coverage here.

    Even in ASPECTS 0-5 stroke patients, successful mechanical thrombectomy reperfusion was associated with favorable outcomes and no higher risk of symptomatic intracerebral hemorrhage, pooled analysis of several institutional registries showed. (Stroke)

    A closure device built for transcaval access achieved 100% technical success in TAVR, according to first-in-human research presented at the Cardiovascular Research Technologies meeting. (CRTonline.org)

    Two layers of bare metal stents together over a covered stent for coronary artery aneurysm treatment could offer flexibility and easier deliverability. In a case series from China, all nine patients treated with this approach got successful stent placement and were symptom-free at 6 months. (EuroIntervention)

    Coronary flow indices with the best test-retest repeatability were fractional flow reserve, absolute coronary blood flow, and absolute microvascular resistance, according to lab experiments. Reproducibility was weaker for the index of microvascular resistance and poor for coronary flow reserve. (Catheterization and Cardiovascular Interventions)

    Source:

    Read the original article on Medpage Today: PAD Device Controversy Continues; TAVR Leaflet Laceration; Coronary Flow Reproducibility

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details